[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.70 -3.21% 81.40 81.40 82.00 82.40 81.40 81.60 1,386,210 12:33:57
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 65.3 15.4 2.5 33.2 370

Ekf Diagnostics Share Discussion Threads

Showing 3526 to 3549 of 3875 messages
Chat Pages: Latest  143  142  141  140  139  138  137  136  135  134  133  132  Older
DateSubjectAuthorDiscuss
20/5/2021
13:52
Re: A J Bell. Be aware that if you use their Secure Message system (as they request) it does not allow symbols, so you cannot use a £ sign! Cd
cambridgedon
20/5/2021
13:03
AJBell must be watching in, literally got the message from them now with mistakes on the name Tellus instead of Trellus and not giving an option to ask for more shares except by emailing them. Good so far....not
mg1982
20/5/2021
12:49
both AJBell and HL have yet to say anything. I have messaged both but still no response. It will be a last minute mad rush like last time with VRCI
mg1982
20/5/2021
11:51
Mine have been showing in my II account for some time under a strange symbol of 9876536, with no value against them. Presumably these are the ones that are locked up?
adobbing
20/5/2021
11:44
My daughter, who is with II, has just got her IPO details (less the price which is yet to be set!) She also told me that the free shares are already being shown on her account. Why can't the other brokers/platforms do this? (FAO A J Bell.) CD
cambridgedon
20/5/2021
11:42
Had the same message as sharw on my II account. Your option appears only to be to “pledge” your cash amount. With a deadline of today? Your pledge may be cut back if oversubscribed. Not sure how they assess that without a share price, presumably if you pledge £1000 they could scale that back, so that you end up paying less? Then when they assess the demand they decide on the price of the shares and therefore the price of each share. Here’s hoping it’s £1000 per share, then the ones I’ve already got could be worth a few ££ !
adobbing
20/5/2021
10:51
Walbrook just advuised there will be announcements from them this afternoon. They will state the price of the share, give access to the application form and require completion by Monday lunchtime.
faz
20/5/2021
10:37
From AJBEll yesterday I’ve spoken to our Corporate Actions Team who are aware of the event and monitoring for the documents being released today. Once the finer details are available, they’ll send a corporate action notice to your online account detailing how to apply for the shares.
faz
20/5/2021
10:27
Congrats sharw, you're evidently with a decent broker! Barclays have confirmed (1) they don't allow clients to participate in new IPOs, and (2) that Broadway are holding Trellus shares on trust for holders for 365 days from admission (from memory), so won't be allocating them around to the various stockbrokers until that time has elapsed. Rather than phoning up all and sundry to find a way round (1), does anyone know of one? Perhaps Broadway themselves can enable something to happen? And what implication does (2) above have for holders of Trellus post-IPO who wish to sell their shares if they shoot up (for example), given that they won't be distributed out to holders for a year? EDIT - apologies, as regards (2) I doubt there's anything anyone can do as: "All such converted shares will be locked-up for a period of twelve months following Admission but new Trellus Shares acquired through the Restricted Offer will not be subject to lock-up."
rivaldo
20/5/2021
10:01
email from ii this morning telling me to check out notice of corporate action. On my a/c it says: Restricted Offer Subscription price: To be confirmed New shares: Upon receipt Tellus Health plc has announced a Restricted Offer, whereby holders may subscribe for additional shares in the company. Your options are: OPTION 1: Do nothing (Default). You will keep your current holding if you take no action. OPTION 2: Subscribe for New Shares. You need to specify the total amount of cash you wish to invest. Subscriptions may be subject to scaling back. Please ensure you have cleared funds in your account by our deadline date. At time of writing the company have not announced the subscription price, nor have they issued an application form,and we have so far been unable to clarify full details of the acceptance procedure with their broker. We have also not been able to confirm for certain if we are eligible to participate or not. Therefore, any elections will be done on a reasonable endeavours basis. Normally we would clarify this information before writing out to you, however given the very short response deadline set by the company that is not feasible in this instance.
sharw
20/5/2021
09:56
Nothing on the Tellus IPO yet from A J Bell (I've alerted them.) Has anyone had notification from their platform provider? CD
cambridgedon
20/5/2021
08:17
Those who attended the AGM meeting will have noted why JB, in answer to a question, indicated why, on several important fronts, that the private sector partner is not ultimately regarded as a threat. So, with that in mind it's worth considering the following excerpt from the AGM Statement - One of the great strengths of our business has been the establishment of an enviable distribution network in Point-of-care and we believe we are well positioned to maximise the value of this network, both for existing and new EKF product deployments as well as after providing development services for white labelled third-party products, leveraging already strong customer relationships. (End) With the above in mind, the following makes for an interesting read, in terms of what a strong relationship with private sector partner could achieve - What Amazon's potential move into at-home medical tests could mean for the market by Heather Landi | May 19, 2021 Taking a look at Amazon's investments over the last few years, including its acquisition of PillPack and launch of Amazon Pharmacy, the focus on employer health, investments in home diagnostics due to the pandemic, and the announcement and expansion of Amazon Care, home testing and diagnostic lab services seems a likely area for Amazon to expand its healthcare ambitions, analysts say. "Labs are a particularly good fit for the core strengths of Amazon. Distribution and supply chain, scale and cost advantage, and digital customer and patient engagement all pointed at reducing friction and likely ultimately improving use and access frequency," Nathan Ray, a director in the healthcare and life sciences practice at business and technology consulting firm West Monroe, told Fierce Healthcare. Amazon also made a major move into the health wearables market with the launch of the Amazon Halo fitness tracker last year. There is the potential for the tech giant to create synergies with its different healthcare plays, Michael Abrams, a managing partner at consulting firm Numerof & Associates, told Fierce Healthcare. "The Halo device can monitor the vitals of someone with a chronic disease, Alexa can then remind them that it's time to make an appointment they can do a virtual visit and also get a test kit in the mail for lab testing. It's all very synergistic," he said. Abrams added, "They are taking steps that are synergistic. Amazon Care is synergistic with Amazon Pharmacy and both of them would be synergistic with a diagnostics line of business as well." A potential expansion into health diagnostics would represent the next phase of growth for Amazon's in-house COVID-19 testing lab as the threat of the COVID-19 pandemic diminishes. Business Insider reported that the company previously said it had spent "hundreds of millions of dollars" in building the lab. "When Amazon puts a lot of money into something that has potential in the healthcare marketplace, they try it out with their employees and, if it works well, they take it public," Abrams said, noting the expansion of Amazon Care to other companies as an employee benefit. Beyond COVID-19 testing, Amazon's potential move into diagnostics is most interesting in the broader employer space, Ray said. "There is the potential to help employers receive better population-level information on their entire workforce including those that do not frequently engage with the health system. It could also be an interesting marketplace for new diagnostic test providers and even for your own physician to more easily and regularly order testing," he said. This week, Amazon rolled out a new employee wellness program called WorkingWell, aimed at preventing injuries, providing wellness services, and offering quality healthcare for employees while at work and at home. By the end of 2021, WorkingWell will expand further to cover all of Amazon’s operations network in the U.S. with the aim of cutting recordable incident rates by 50 percent by 2025, the company announced in a press release. A move into home diagnostics would put Amazon in direct competition with testing giants LabCorp and Quest as well as other at-home testing kit startups. Retailers such as Kroger, Walmart and Albertsons launched their own home-testing services for general consumers over the past year, Business Insider reported. "I think we're on the verge of an explosion in at-home diagnostics, considering the new technologies out there," said Abrams. He speculated that if Amazon jumped into the diagnostics space the company would take the same merchandising approach as with its other products by offering third-party lines and launching its own line of diagnostics. "Existing players in the space might have to sell through Amazon’s platform and hoping that they don’t choose to come out with their own brand of at-home diagnostics. That’s a tough fight to win as it will drive margins down," he said. Full story - hTTps://www.fiercehealthcare.com/tech/what-amazon-s-potential-move-into-at-home-medical-tests-could-mean-for-market To my mind, EKF's development services for white labelled third-party products should sit very well in providing for certain private sector partners ambitions for own brand of at-home diagnostics.
wan
20/5/2021
07:26
Worthy of note today - SourceBio International PLC National Framework contract 20/05/2021 SourceBio International accepted for UK-wide National Microbiology Framework (Lot 4) tender and Further COVID-19 Government testing approvals for Day 2 and Day 8 testing Full release - hTTps://uk.advfn.com/stock-market/london/sourcebio-SBI/share-news/SourceBio-International-PLC-National-Framework-con/85163761
wan
19/5/2021
22:06
How much are the Trellus shares going for, or is that about to be announced?
adobbing
19/5/2021
21:44
Draft Admission document here: https://trellushealth.com/investors/
mirandaj
19/5/2021
21:09
ppmm, I didn't manage to dial in but have met Julian Baines many times and he's always been forthright and open - even after Stanbio acquisition and in a somewhat painful period for the company. So agree with your sentiments. And I emailed the Trellus CFO and he emailed back (pretty quickly) confirming it is planned for tomorrow, so hopefully my ISA provider will be on the ball so I can participate in the restricted offer.
cisk
19/5/2021
20:49
I listened to the AGM today and have listened to a few of the companies i’m invested in or considering recently. The kind of detail regarding the business and future plans that EKF have willingly given I think is a shareholder is invaluable and resulted in the removal of any doubts during the recent selloff and helps plan my portfolio into the future.
ppmm
19/5/2021
20:41
Cisk, it says that information will be made available once the pricing and the raising of funds has been confirmed. That’s expected on 19th or shortly after. No information yet so may be tomorrow.
ppmm
19/5/2021
16:51
thanks ppmm, I'm out of the country at the moment so cannot access the investor section of trellus website... I've emailed them but not hopeful for a timely reply
cisk
19/5/2021
16:23
EKF are to be commended on their AGM statement today in terms of its clarity over a number of key areas - many others in the sector could learn from this.
nxc
19/5/2021
15:20
Yes, the process is set out on the investor section of the trellus website but the pricing and shares available are expected to be known some time today apparently
ppmm
19/5/2021
14:11
Does anyone know how to apply for extra trellus shares? Hold mine through ii isa so guess I have to go through them?
cisk
19/5/2021
12:29
The cannabidiol market is predicted to increase from $2.8 bn at a CAGR of 52.7% from 2020-2026 and I forgot that it was in fact referenced to EKF's new Purissima account win during a previous meeting (I checked my notes). Background - SAN FRANCISCO--(BUSINESS WIRE)-- Purissima, a health and wellness company, announced their launch today. Purissima has developed a bio-based ingredient platform technology that enables large-scale production and supply of natural, high-demand compounds currently derived from plant sources. Purissima partners with leading brands in the global health and wellness industry to provide pure, natural compounds and pharmaceuticals, made-to-order, at unprecedented commercial scale and economics for everyday personal care, consumer health and nutrition. The ingredients support overall health and nutrition, plus provide affordable, high-impact therapeutics for people suffering from a wide range of neurological and metabolic indications, chronic pain, inflammation, sleep disorders, cancer and other chronic conditions that impact most individuals at some point in their lifetimes. hTTps://purissima.bio/wp-content/uploads/2019/11/Purissima-press-release-launch_November-14-FINAL-FINAL_2.pdf Investors will note the reference to addressing a wide range of health related conditions, including chronic conditions (whether there is any read across to treating IBD remains to be seen).
wan
19/5/2021
12:16
Apologies, I think the new customer for synthetic cannabanoid may in fact be Purissima - hTTps://purissima.bio/ Nonetheless, Stepan is a very large new customer that I believe also requires large scale fermenters.
wan
Chat Pages: Latest  143  142  141  140  139  138  137  136  135  134  133  132  Older
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210920 12:41:07